India's Alembic Pharma gains after US FDA nod for hypertension drug

Alembic Pharmaceuticals

19/08/2025 08:28

** Shares of Alembic Pharmaceuticals Ltd ALEM.NS rise as much as 2.8% to 999 rupees

** Stock on track to gain for third straight session
** Co gets final approval from the U.S. Food and Drug Administration (USFDA) for Macitentan Tablets, 10 mg, used to treat pulmonary arterial hypertension
** Mean rating of stock is 'buy'; their median PT is 990 rupees - data compiled by LSEG
** ALEM last up 0.7%, cutting YTD losses to 8.9%

 (Reporting by Meenakshi Maidas in Bengaluru)

 ((meenakshi.maidas@thomsonreuters.com;))